News & Press Releases

Mintz advised the underwriters in connection with MoonLake Immunotherapeutics’ $200 million public offering of Class A ordinary shares.

Mintz served as health regulatory counsel to LucyRx, a technology-enabled pharmacy benefit manager (PBM), in its strategic combination with Abarca Health, creating a modern, independent PBM designed to serve commercial and government clients at scale.

Mintz advised the underwriters in connection with uniQure’s $259 million public offering of ordinary shares.

Mintz will receive a 2026 Beacon of Justice Award from the National Legal Aid & Defender Association (NLADA) in recognition of the firm’s efforts to protect democracy and civil society, marking the seventh consecutive year Mintz has been honored with this award.

Mintz served as legal counsel to Innovius Capital Management in connection with its role as lead investor in the $46 million Series B financing of xCures, an Oakland-based digital health company developing AI-driven solutions for medical record acquisition and analysis.

Mintz represented SYN Ventures, a leading cybersecurity-focused venture capital firm, as lead investor in a $60 million Series A financing in Arcade, a company building the secure action layer for production AI agents.